Literature DB >> 10844385

Changes in the mRNA levels of delayed rectifier potassium channels in human atrial fibrillation.

L P Lai1, M J Su, J L Lin, F Y Lin, C H Tsai, Y S Chen, Y Z Tseng, W P Lien, S K Huang.   

Abstract

INTRODUCTION: We measured mRNA levels of delayed rectifier potassium channels in human atrial tissue to investigate the mechanism of the shortening of the atrial effective refractory period and the loss of rate-adaptive shortening of the atrial effective refractory period in human atrial fibrillation. METHODS AND
RESULTS: A total of 34 patients undergoing open heart surgery were included. Atrial tissue was obtained from the right atrial free wall, right atrial appendage, left atrial free wall and left atrial appendage, respectively. The mRNA amounts of KVLQT1 (IKs), minK (beta-subunit of IKs), HERG (IKr), and KV1.5 (IKur) were measured by reverse transcription-polymerase chain reaction and normalized to the mRNA amount of GAPDH. We found that the mRNA levels of KV1.5, HERG and KVLQT1 were all significantly decreased in patients with persistent atrial fibrillation for more than 3 months. In contrast, the mRNA level of minK was significantly increased in patients with persistent atrial fibrillation for more than 3 months. We further showed that these changes were independent of the underlying cardiac disease, atrial filling pressure, gender and age. We also found that there was no spatial dispersion of mRNA levels among the four atrial sampling sites.
CONCLUSIONS: Because the decrease in potassium currents results in a prolonged action potential, the shortening of the atrial effective refractory period in atrial fibrillation should be attributed to other factors. However, the decrease in IKs might contribute, at least in part, to the loss of rate-adaptive shortening of the atrial refractory period.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10844385     DOI: 10.1159/000006982

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  8 in total

1.  Long-term modulation of Na+ and K+ channels by TGF-β1 in neonatal rat cardiac myocytes.

Authors:  Roberto Ramos-Mondragón; Ana Victoria Vega; Guillermo Avila
Journal:  Pflugers Arch       Date:  2011-01-13       Impact factor: 3.657

Review 2.  Monogenic atrial fibrillation as pathophysiological paradigms.

Authors:  Saagar Mahida; Steven A Lubitz; Michiel Rienstra; David J Milan; Patrick T Ellinor
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

3.  Electrophysiological properties of human mesenchymal stem cells.

Authors:  Jürgen F Heubach; Eva M Graf; Judith Leutheuser; Manja Bock; Bartosz Balana; Ihor Zahanich; Torsten Christ; Sabine Boxberger; Erich Wettwer; Ursula Ravens
Journal:  J Physiol       Date:  2003-10-24       Impact factor: 5.182

Review 4.  Redox regulation, NF-kappaB, and atrial fibrillation.

Authors:  Ge Gao; Samuel C Dudley
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 5.  Cardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial Fibrillation.

Authors:  Ademuyiwa S Aromolaran; Mohamed Boutjdir
Journal:  Front Physiol       Date:  2017-06-21       Impact factor: 4.566

6.  Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria.

Authors:  Michael A Colman; Oleg V Aslanidi; Sanjay Kharche; Mark R Boyett; Clifford Garratt; Jules C Hancox; Henggui Zhang
Journal:  J Physiol       Date:  2013-06-03       Impact factor: 5.182

Review 7.  Role of TGF-beta on cardiac structural and electrical remodeling.

Authors:  Roberto Ramos-Mondragón; Carlos A Galindo; Guillermo Avila
Journal:  Vasc Health Risk Manag       Date:  2008

8.  Remodeling of Kv1.5 channel in right atria from Han Chinese patients with atrial fibrillation.

Authors:  Xian-hong Ou; Miao-ling Li; Rui Liu; Xin-rong Fan; Liang Mao; Xue-hui Fan; Yan Yang; Xiao-rong Zeng
Journal:  Med Sci Monit       Date:  2015-04-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.